76 related articles for article (PubMed ID: 1561466)
41. Acute and sustained effects of isosorbide 5-mononitrate in stable angina pectoris.
Kohli RS; Rodrigues EA; Kardash MM; Whittington JR; Raftery EB
Am J Cardiol; 1986 Oct; 58(9):727-31. PubMed ID: 3766413
[TBL] [Abstract][Full Text] [Related]
42. [Lack of tolerance after administration of delayed-action isosorbide-5-mononitrate for 3 days in patients with exercise-induced silent ischemia: control with placebo].
Scardi S; Pandullo C; Humar F; Spanghero M; Mazzone C
G Ital Cardiol; 1992 May; 22(5):549-57. PubMed ID: 1426792
[TBL] [Abstract][Full Text] [Related]
43. Hemodynamic effects of isosorbide-5-mononitrate in acute and chronic treatment of coronary heart disease.
Schuster P; Trieb G; Wiechmann HW
Z Kardiol; 1983; 72 Suppl 3():251-4. PubMed ID: 6666229
[TBL] [Abstract][Full Text] [Related]
44. Twenty-four-hour activity of felodipine extended release in chronic stable angina pectoris.
Santoro G; Savonitto S; Di Bello V; Alberti D; Giusti C
Am J Cardiol; 1991 Aug; 68(5):457-62. PubMed ID: 1872271
[TBL] [Abstract][Full Text] [Related]
45. Effects of nicorandil on exercise tolerance in patients with stable effort angina: a double-blind study.
Hayata N; Araki H; Nakamura M
Am Heart J; 1986 Dec; 112(6):1245-50. PubMed ID: 2947447
[TBL] [Abstract][Full Text] [Related]
46. Long-acting, marked antiischemic effect maintained unattenuated during long-term interval treatment with once-daily isosorbide-5-mononitrate in sustained-release form.
Beyerle A; Reiniger G; Rudolph W
Am J Cardiol; 1990 Jun; 65(22):1434-7. PubMed ID: 2191582
[TBL] [Abstract][Full Text] [Related]
47. Differences in response to single dose and steady-state therapy with verapamil in stable angina.
Vazquez de Prada JA; Zueco J; Ruano J; Martin-Duran R; Sanjose JM; Colman T; Pajaron A
Int J Cardiol; 1991 Sep; 32(3):339-45. PubMed ID: 1791086
[TBL] [Abstract][Full Text] [Related]
48. Acute effect of various doses of isosorbide-5-mononitrate on hemodynamic and exercise performance in coronary artery disease.
Jansen W; Meyer L; Tauchert M
Am J Cardiol; 1988 Mar; 61(9):31E-35E. PubMed ID: 3348138
[TBL] [Abstract][Full Text] [Related]
49. [Prolonged treatment with isosorbide-5-mononitrate in patients with silent ischemia].
Almenar L; Gimeno JV; Palencia M; Algarra F
Rev Esp Cardiol; 1995 Jan; 48(1):49-54. PubMed ID: 7878282
[TBL] [Abstract][Full Text] [Related]
50. 24-hour anti-ischaemic action with once daily nifedipine. Experience obtained with a fatty-alcohol matrix tablet in patients with coronary artery disease.
Woodcock BG; Thürmann PA; Pfleiderer S; Reifart N
Eur J Clin Pharmacol; 1992; 43(6):587-90. PubMed ID: 1493838
[TBL] [Abstract][Full Text] [Related]
51. [Acebutolol in coronary heart disease: an ergometric double-blind study (author's transl)].
Böhm H; Ludwig B
Dtsch Med Wochenschr; 1980 Jul; 105(27):958-60. PubMed ID: 7408684
[TBL] [Abstract][Full Text] [Related]
52. Double-blind randomised placebo-controlled dose-efficacy study of sustained release verapamil in chronic stable angina.
Gibbs JS; McAlpine HM; Wright C; McLenachan JM; Sparrow J; Sutton G; Dargie HJ; Fox KM
Int J Cardiol; 1991 Jun; 31(3):281-6. PubMed ID: 1879977
[TBL] [Abstract][Full Text] [Related]
53. Exercise capacity after acute aminophylline administration in angina pectoris.
Picano E; Pogliani M; Lattanzi F; Distante A; L'Abbate A
Am J Cardiol; 1989 Jan; 63(1):14-6. PubMed ID: 2909150
[TBL] [Abstract][Full Text] [Related]
54. An assessment of single doses of 8 mg sustained-release molsidomine using serial exercise tests.
Ruano J; Zueco J; López C; Colman T; Arnau C; Pajarón A
Eur Heart J; 1988 Apr; 9(4):403-11. PubMed ID: 3383879
[TBL] [Abstract][Full Text] [Related]
55. Propionyl-L-carnitine: a new compound in the metabolic approach to the treatment of effort angina.
Lagioia R; Scrutinio D; Mangini SG; Ricci A; Mastropasqua F; Valentini G; Ramunni G; Totaro Fila G; Rizzon P
Int J Cardiol; 1992 Feb; 34(2):167-72. PubMed ID: 1737667
[TBL] [Abstract][Full Text] [Related]
56. Effects of captopril on the physical work capacity of normotensive patients with stable-effort angina pectoris.
Strozzi C; Cocco G; Portaluppi F; Urso L; Alfiero R; Tasini MT; Montanari L; Al Yassini K; Rizzo A
Cardiology; 1987; 74(3):226-8. PubMed ID: 3297325
[TBL] [Abstract][Full Text] [Related]
57. [A comparison of the efficacy of nitrogranulong and other prolonged-action nitrates by using paired bicycle ergometry in patients with stenocardia].
Bochkareva EV; Kokurina EV; Metelitsa VI; Kukushkin SK
Kardiologiia; 1992 Jul; 32(7-8):61-4. PubMed ID: 1487885
[TBL] [Abstract][Full Text] [Related]
58. [Effect of 2- and 5-isosorbide nononitrate on the exercise-ECG of patients with coronary insufficiency].
Stauch M; Grewe N; Nissen H
Verh Dtsch Ges Kreislaufforsch; 1975; 41():182-4. PubMed ID: 1231310
[No Abstract] [Full Text] [Related]
59. [Study of oral Pindolol on exercise tolerance in angina pectoris].
Broustet JP; Dubecq M; Daubèze J; Emeriau JP; Bricaud H
Coeur Med Interne; 1976; 15(1):97-106. PubMed ID: 1000921
[No Abstract] [Full Text] [Related]
60. Ergometric evaluation of the effects of enalapril maleate in normotensive patients with stable angina.
Strozzi C; Portaluppi F; Cocco G; Urso L
Clin Cardiol; 1988 Apr; 11(4):246-9. PubMed ID: 2835195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
